CCL18 and diabetes mellitus: Analysis of anti-inflammatory cell activity by measuring of basal and stimulated anti-inflammatory chemokine (CCL18) secretion levels showed significantly higher chemokine levels in patients with newly diagnosed T2DM compared to patients with long-term diabetes and accounted for 27.5 (14.5; 43.5) pg/mL.